Literature DB >> 23985903

Oxidative stress modulates vascular smooth muscle cell phenotype via CTGF in thoracic aortic aneurysm.

Emanuela Branchetti1, Paolo Poggio, Rachana Sainger, Eric Shang, Juan B Grau, Benjamin M Jackson, Eric K Lai, Michael S Parmacek, Robert C Gorman, Joseph H Gorman, Joseph E Bavaria, Giovanni Ferrari.   

Abstract

AIMS: Dissection and rupture of the ascending aorta are life-threatening conditions resulting in 80% mortality. Ascending aortic replacement in patients presenting with thoracic aortic aneurysm (TAA) is determined by metric measurement. However, a significant number of dissections occur outside of the parameters suggested by the current guidelines. We investigate the correlation among altered haemodynamic condition, oxidative stress, and vascular smooth muscle cell (VSMC) phenotype in controlling tissue homoeostasis. METHODS AND
RESULTS: We demonstrate using finite element analysis (FEA) based on computed tomography geometries that TAA patients have higher wall stress in the ascending aorta than non-dilated patients. We also show that altered haemodynamic conditions are associated with increased levels of reactive oxygen species (ROS), direct regulators of the VSMC phenotype in the microregional area of the ascending aorta. Using in vitro and ex vivo studies on human tissues, we show that ROS accumulation correlates with media layer degeneration and increased connective tissue growth factor (CTGF) expression, which modulate the synthetic VSMC phenotype. Results were validated by a murine model of TAA (C57BL/6J) based on Angiotensin II infusion showing that medial thickening and luminal expansion of the proximal aorta is associated with the VSMC synthetic phenotype as seen in human specimens.
CONCLUSIONS: Increased peak wall stress correlates with change in VSMC towards a synthetic phenotype mediated by ROS accumulation via CTGF. Understanding the molecular mechanisms that regulate VSMC towards a synthetic phenotype could unveil new regulatory pathways of aortic homoeostasis and impact the risk-stratification tool for patients at risk of aortic dissection and rupture.

Entities:  

Keywords:  CTGF; ROS; Thoracic aortic aneurysm; VSMC phenotype

Mesh:

Substances:

Year:  2013        PMID: 23985903      PMCID: PMC4192047          DOI: 10.1093/cvr/cvt205

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  45 in total

Review 1.  Molecular determinants of vascular smooth muscle cell diversity.

Authors:  Tadashi Yoshida; Gary K Owens
Journal:  Circ Res       Date:  2005-02-18       Impact factor: 17.367

2.  Wall strength and stiffness of aneurysmal and nonaneurysmal abdominal aorta.

Authors:  D A Vorp; M L Raghavan; S C Muluk; M S Makaroun; D L Steed; R Shapiro; M W Webster
Journal:  Ann N Y Acad Sci       Date:  1996-11-18       Impact factor: 5.691

3.  Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves.

Authors:  Scott A LeMaire; Xinwen Wang; Jonathan A Wilks; Stacey A Carter; Shixiang Wen; Taehee Won; Dominic Leonardelli; Gobind Anand; Lori D Conklin; Xing Li Wang; Robert W Thompson; Joseph S Coselli
Journal:  J Surg Res       Date:  2005-01       Impact factor: 2.192

4.  Increased collagen deposition and elevated expression of connective tissue growth factor in human thoracic aortic dissection.

Authors:  Xinwen Wang; Scott A LeMaire; Li Chen; Ying H Shen; Yehua Gan; Heather Bartsch; Stacey A Carter; Budi Utama; Hesheng Ou; Joseph S Coselli; Xing Li Wang
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

5.  Familial thoracic aortic aneurysms and dissections--incidence, modes of inheritance, and phenotypic patterns.

Authors:  Gonzalo Albornoz; Michael A Coady; Michele Roberts; Ryan R Davies; Maryann Tranquilli; John A Rizzo; John A Elefteriades
Journal:  Ann Thorac Surg       Date:  2006-10       Impact factor: 4.330

6.  Natural history of ascending aortic aneurysms in the setting of an unreplaced bicuspid aortic valve.

Authors:  Ryan R Davies; Ryan K Kaple; Divakar Mandapati; Amy Gallo; Donald M Botta; John A Elefteriades; Michael A Coady
Journal:  Ann Thorac Surg       Date:  2007-04       Impact factor: 4.330

7.  Oxidative stress in the pathogenesis of thoracic aortic aneurysm: protective role of statin and angiotensin II type 1 receptor blocker.

Authors:  Junya Ejiri; Nobutaka Inoue; Takuro Tsukube; Takashi Munezane; Yutaka Hino; Seiichi Kobayashi; Ken-ichi Hirata; Seinosuke Kawashima; Shinobu Imajoh-Ohmi; Yoshitake Hayashi; Hiroshi Yokozaki; Yutaka Okita; Mitsuhiro Yokoyama
Journal:  Cardiovasc Res       Date:  2003-10-01       Impact factor: 10.787

Review 8.  Molecular regulation of vascular smooth muscle cell differentiation in development and disease.

Authors:  Gary K Owens; Meena S Kumar; Brian R Wamhoff
Journal:  Physiol Rev       Date:  2004-07       Impact factor: 37.312

9.  Synthetic smooth muscle cell phenotype is associated with increased nicotinamide adenine dinucleotide phosphate oxidase activity: effect on collagen secretion.

Authors:  Rajendra Patel; Jeffry D Cardneau; Scott M Colles; Linda M Graham
Journal:  J Vasc Surg       Date:  2006-02       Impact factor: 4.268

Review 10.  Bicuspid aortic valve: clinical approach and scientific review of a common clinical entity.

Authors:  Tamir Friedman; Arya Mani; John A Elefteriades
Journal:  Expert Rev Cardiovasc Ther       Date:  2008-02
View more
  43 in total

1.  Comparative genome-wide transcriptional analysis of human left and right internal mammary arteries.

Authors:  Giovanni Ferrari; John Quackenbush; John Strobeck; Lan Hu; Christopher K Johnson; Andrew Mak; Richard E Shaw; Kathleen Sayles; Mariano E Brizzio; Alex Zapolanski; Juan B Grau
Journal:  Genomics       Date:  2014-05-20       Impact factor: 5.736

2.  NLRP3 (Nucleotide Oligomerization Domain-Like Receptor Family, Pyrin Domain Containing 3)-Caspase-1 Inflammasome Degrades Contractile Proteins: Implications for Aortic Biomechanical Dysfunction and Aneurysm and Dissection Formation.

Authors:  Darrell Wu; Pingping Ren; Yanqiu Zheng; Lin Zhang; Gaiping Xu; Wanmu Xie; Eric E Lloyd; Sui Zhang; Qianzi Zhang; John A Curci; Joseph S Coselli; Dianna M Milewicz; Ying H Shen; Scott A LeMaire
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-02-02       Impact factor: 8.311

3.  The C-terminal module IV of connective tissue growth factor, through EGFR/Nox1 signaling, activates the NF-κB pathway and proinflammatory factors in vascular smooth muscle cells.

Authors:  Raúl R Rodrigues-Diez; Ana Belen Garcia-Redondo; Macarena Orejudo; Raquel Rodrigues-Diez; Ana Maria Briones; Enrique Bosch-Panadero; Gyorgy Kery; Janos Pato; Alberto Ortiz; Mercedes Salaices; Jesus Egido; Marta Ruiz-Ortega
Journal:  Antioxid Redox Signal       Date:  2015-01-01       Impact factor: 8.401

Review 4.  Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections.

Authors:  Ying H Shen; Scott A LeMaire
Journal:  Curr Probl Surg       Date:  2017-02-03       Impact factor: 1.909

Review 5.  Aortic Aneurysms and Dissections Series.

Authors:  Ying H Shen; Scott A LeMaire; Nancy R Webb; Lisa A Cassis; Alan Daugherty; Hong S Lu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-02-26       Impact factor: 8.311

6.  Serotonin receptor 2B signaling with interstitial cell activation and leaflet remodeling in degenerative mitral regurgitation.

Authors:  Kathryn H Driesbaugh; Emanuela Branchetti; Juan B Grau; Samuel J Keeney; Kimberly Glass; Mark A Oyama; Nancy Rioux; Salma Ayoub; Michael S Sacks; John Quackenbush; Robert J Levy; Giovanni Ferrari
Journal:  J Mol Cell Cardiol       Date:  2017-12-30       Impact factor: 5.000

7.  Chronic mTOR activation induces a degradative smooth muscle cell phenotype.

Authors:  Guangxin Li; Mo Wang; Alexander W Caulk; Nicholas A Cilfone; Sharvari Gujja; Lingfeng Qin; Pei-Yu Chen; Zehua Chen; Sameh Yousef; Yang Jiao; Changshun He; Bo Jiang; Arina Korneva; Matthew R Bersi; Guilin Wang; Xinran Liu; Sameet Mehta; Arnar Geirsson; Jeffrey R Gulcher; Thomas W Chittenden; Michael Simons; Jay D Humphrey; George Tellides
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

Review 8.  Connective tissue growth factor (CTGF) in age-related vascular pathologies.

Authors:  Zoltan Ungvari; Marta Noa Valcarcel-Ares; Stefano Tarantini; Andriy Yabluchanskiy; Gábor A Fülöp; Tamas Kiss; Anna Csiszar
Journal:  Geroscience       Date:  2017-09-05       Impact factor: 7.713

9.  Simvastatin ameliorates low-dose streptozotocin-induced type 2 diabetic nephropathy in an experimental rat model.

Authors:  Siwei Zhang; Huali Xu; Xiaofeng Yu; Yuchen Wang; Fanfan Sun; Dayuan Sui
Journal:  Int J Clin Exp Med       Date:  2015-04-15

10.  Matricellular protein CCN3 mitigates abdominal aortic aneurysm.

Authors:  Chao Zhang; Dustin van der Voort; Hong Shi; Rongli Zhang; Yulan Qing; Shuichi Hiraoka; Minoru Takemoto; Koutaro Yokote; Joseph V Moxon; Paul Norman; Laure Rittié; Helena Kuivaniemi; G Brandon Atkins; Stanton L Gerson; Guo-Ping Shi; Jonathan Golledge; Nianguo Dong; Bernard Perbal; Domenick A Prosdocimo; Zhiyong Lin
Journal:  J Clin Invest       Date:  2016-03-14       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.